Predictable Clinical Benefits without Evidence of Synergy in Trials of Combination Therapies with Immune-Checkpoint Inhibitors

Overview of attention for article published in Clinical Cancer Research, January 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 9 news outlets
blogs: 2 blogs

twitter: 121 tweeters
facebook: 2 Facebook pages

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 57 Mendeley

Summary News Blogs Twitter Facebook Dimensions citations

So far, Altmetric has seen 2 posts from 2 blogs.

Terapie di combinazione, i misteri della sinergia d’azione

OncoInfo, 25 Feb 2022

Dallo studio dell’interazione farmacologica alla comprensione del meccanismo che sottende l’enorme variabilità della risposta.

This week in MathOnco 198

This week in Mathematical Oncology, 24 Feb 2022

“This week in Mathematical Oncology” — Feb. 24, 2022> mathematical-oncology.orgFrom the editor: This week’s edition focuses on…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.